Literature DB >> 18431670

Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking.

Punit P Shah1, Rajashree C Mashru, Yogesh M Rane, Arti Thakkar.   

Abstract

The objective of the present investigation was to reduce the bitterness with improved dissolution, in acidic medium (pH 1.2), of mefloquine hydrochloride (MFL). Microparticles were prepared by coacervation method using Eudragit E (EE) as polymer and sodium hydroxide as precipitant. A 3(2) full factorial design was used for optimization wherein the drug concentration (A) and polymer concentration (B) were selected as independent variables and the bitterness score, particle size and dissolution at various pH were selected as the dependent variables. The desirability function approach has been employed in order to find the best compromise between the different experimental responses. The model is further cross validated for bias. The optimized microparticles were characterized by FT-IR, DSC, XRPD and SEM. Bitterness score was evaluated by human gustatory sensation test. Multiple linear regression analysis revealed that the reduced bitterness of MFL can be obtained by controlling the dissolution of microparticles at pH 6.8 and increasing the EE concentration. The increase in polymer concentration leads to reduction in dissolution of microparticles at pH > 5 due to its insolubility. However the dissolution studies at pH 1.2 demonstrated enhanced dissolution of MFL from microparticles might be due to the high porosity of the microparticles, hydrophilic nature of the EE, and improved wettability, provided by the dissolved EE. The bitterness score of microparticles was decreased to zero compared to 3+ of pure ARM. In conclusion the bitterness of MFL was reduced with improved dissolution at acidic pH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431670      PMCID: PMC2976944          DOI: 10.1208/s12249-008-9052-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  25 in total

1.  Taste masking as a consequence of the organisation of powder mixes.

Authors:  J Barra; F Lescure; E Doelker
Journal:  Pharm Acta Helv       Date:  1999-12

2.  Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics.

Authors:  E Esposito; R Roncarati; R Cortesi; F Cervellati; C Nastruzzi
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

3.  The influence of film coating on pellet properties.

Authors:  Ranjana Chopra; Göran Alderborn; J Michael Newton; Fridrun Podczeck
Journal:  Pharm Dev Technol       Date:  2002-01       Impact factor: 3.133

4.  Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design.

Authors:  M C Gohel; M K Panchal
Journal:  Drug Dev Ind Pharm       Date:  2002-01       Impact factor: 3.225

5.  A novel method for preparation of Eudragit RL microcapsules.

Authors:  P M Satturwar; P M Mandaogade; A K Dorle
Journal:  J Microencapsul       Date:  2002 Jul-Aug       Impact factor: 3.142

6.  Evaluation of solid dispersion particles prepared with SEDS.

Authors:  Anne Mari Juppo; Catherine Boissier; Cynthia Khoo
Journal:  Int J Pharm       Date:  2003-01-16       Impact factor: 5.875

7.  Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approach.

Authors:  Yogesh M Rane; Rajshree C Mashru; Mayur G Sankalia; Vijay B Sutariya; Punit P Shah
Journal:  Drug Dev Ind Pharm       Date:  2007-09       Impact factor: 3.225

8.  Binders for colon specific drug delivery: an in vitro evaluation.

Authors:  V R Sinha; Rachna Kumria
Journal:  Int J Pharm       Date:  2002-12-05       Impact factor: 5.875

9.  Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease.

Authors:  C S Leopold; D Eikeler
Journal:  Drug Dev Ind Pharm       Date:  2000-12       Impact factor: 3.225

10.  Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine.

Authors:  Yoshimi Hashimoto; Masami Tanaka; Hideyuki Kishimoto; Hiroyoshi Shiozawa; Kazumasa Hasegawa; Kenji Matsuyama; Takahiro Uchida
Journal:  J Pharm Pharmacol       Date:  2002-10       Impact factor: 3.765

View more
  6 in total

1.  Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.

Authors:  Dionysios Dennis Douroumis; Andreas Gryczke; Silke Schminke
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.

Authors:  Punit P Shah; Pinaki R Desai; Debra Channer; Mandip Singh
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

3.  Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.

Authors:  Manjeet B Pimparade; Joseph T Morott; Jun-Bom Park; Vijay I Kulkarni; Soumyajit Majumdar; S N Murthy; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Reena Murthy; H N Shivakumar; K Vanaja; P C Kumar; Michael A Repka
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

4.  Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.

Authors:  Feng-Lin Yen; Tzu-Hui Wu; Liang-Tzung Lin; Thau-Ming Cham; Chun-Ching Lin
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

5.  Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.

Authors:  Jingling Tang; Na Xu; Hongyu Ji; Hongmei Liu; Zhiyong Wang; Linhua Wu
Journal:  Int J Nanomedicine       Date:  2011-10-19

Review 6.  Developments in Taste-Masking Techniques for Traditional Chinese Medicines.

Authors:  Xiao Zheng; Fei Wu; Yanlong Hong; Lan Shen; Xiao Lin; Yi Feng
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.